Tackling Antimicrobial Resistance with Targeted Covalent Macrocycles

Project Code

MRCIIAR25Ba Lovell

Research Theme

Infection, Immunity, Antimicrobial Resistance and Repair

Project Summary Download

Summary

Infections with drug-resistant bacteria are major threats to human health. Discovering novel druggable targets for antimicrobial development is a pivotal task to guarantee effective future treatments. This interdisciplinary project will target WalK, a protein kinase essential for the viability of S. aureus cells. Large libraries of covalent macrocycles will be screened against WalK to identify an inhibitor. Hit-to-lead optimization will be achieved using a suite of chemical, structural and molecular methods. Finally, lead molecules will be applied in vivo using an invertebrate infection model. Ultimately, this work will provide novel antimicrobial compounds ready for pre-clinical assessment in mice. 

Lead Supervisor

Dr Scott Lovell

Lead Supervisor Email

sdl35@bath.ac.uk

University Affiliation

Bath